These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35397003)

  • 1. Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway.
    Parsons RB; Kocinaj A; Ruiz Pulido G; Prendergast SA; Parsons AE; Facey PD; Hirth F
    Hum Mol Genet; 2022 Aug; 31(17):2918-2933. PubMed ID: 35397003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein.
    Goulding SR; Sullivan AM; O'Keeffe GW; Collins LM
    Parkinsonism Relat Disord; 2019 Jul; 64():194-201. PubMed ID: 31000327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity.
    Antenor-Dorsey JA; O'Malley KL
    Mol Neurodegener; 2012 Feb; 7():5. PubMed ID: 22315973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J; Torra A; Vila M; Bové J
    Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies.
    Kawahata I; Finkelstein DI; Fukunaga K
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nmnat3 Is Dispensable in Mitochondrial NAD Level Maintenance In Vivo.
    Yamamoto M; Hikosaka K; Mahmood A; Tobe K; Shojaku H; Inohara H; Nakagawa T
    PLoS One; 2016; 11(1):e0147037. PubMed ID: 26756334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of nicotinamide mononucleotide adenylyltransferase 3 (nmnat3) causes hemolytic anemia by altering the glycolytic flow in mature erythrocytes.
    Hikosaka K; Ikutani M; Shito M; Kazuma K; Gulshan M; Nagai Y; Takatsu K; Konno K; Tobe K; Kanno H; Nakagawa T
    J Biol Chem; 2014 May; 289(21):14796-811. PubMed ID: 24739386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the α-synuclein accumulation in Parkinson's disease.
    Er S; Airavaara M
    Biochem Soc Trans; 2023 Feb; 51(1):245-257. PubMed ID: 36794783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytes Protect Human Dopaminergic Neurons from α-Synuclein Accumulation and Propagation.
    Tsunemi T; Ishiguro Y; Yoroisaka A; Valdez C; Miyamoto K; Ishikawa K; Saiki S; Akamatsu W; Hattori N; Krainc D
    J Neurosci; 2020 Nov; 40(45):8618-8628. PubMed ID: 33046546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies.
    Chopra A; Outeiro TF
    Brain; 2024 Jan; 147(1):81-90. PubMed ID: 37526295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
    Hartlage-Rübsamen M; Bluhm A; Moceri S; Machner L; Köppen J; Schenk M; Hilbrich I; Holzer M; Weidenfeller M; Richter F; Coras R; Serrano GE; Beach TG; Schilling S; von Hörsten S; Xiang W; Schulze A; Roßner S
    Acta Neuropathol; 2021 Sep; 142(3):399-421. PubMed ID: 34309760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson's Disease.
    Kim H; Maeng HJ; Kim JH; Yoon JH; Oh Y; Paek SM; Lee Y
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATPase Thorase Deficiency Causes α-Synucleinopathy and Parkinson's Disease-like Behavior.
    Gao F; Zhang H; Yang J; Cai M; Yang Q; Wang H; Xu Y; Chen H; Hu Y; He W; Zhang J
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho GTPase regulation of α-synuclein and VMAT2: implications for pathogenesis of Parkinson's disease.
    Zhou Z; Kim J; Insolera R; Peng X; Fink DJ; Mata M
    Mol Cell Neurosci; 2011 Sep; 48(1):29-37. PubMed ID: 21699982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
    Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
    Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson's disease.
    Shin JY; Lee B; Ham S; Kim JH; Kim H; Kim H; Jo MG; Kim HJ; Park SW; Kweon HS; Kim YJ; Yun SP; Lee Y
    Biomed Pharmacother; 2022 Dec; 156():113908. PubMed ID: 36283223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity.
    Olsen AL; Feany MB
    Neurobiol Dis; 2021 Nov; 159():105482. PubMed ID: 34390834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport.
    Yang S; Niou ZX; Enriquez A; LaMar J; Huang JY; Ling K; Jafar-Nejad P; Gilley J; Coleman MP; Tennessen JM; Rangaraju V; Lu HC
    Mol Neurodegener; 2024 Jan; 19(1):13. PubMed ID: 38282024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease.
    Gou DH; Huang TT; Li W; Gao XD; Haikal C; Wang XH; Song DY; Liang X; Zhu L; Tang Y; Ding C; Li JY
    Redox Biol; 2021 Jan; 38():101795. PubMed ID: 33232911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.